Skip to content

Insider · CIK 0001810233

Matthew E Gormly

director

Files at JOB (GEE Group Inc.). First filing -, latest -.

In brief

Matthew E Gormly files SEC Form 4 as director at JOB (GEE Group Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Matthew E Gormly has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 10, 2025JOB
GEE Group Inc.
AGrant or award
Option to Purchase Common Stockderivative
+50,000$0.20$9,785175,000Jun 12, 2025
Sep 19, 2023JOB
GEE Group Inc.
AGrant or award
Option to Purchase Common Stockderivative
+50,000$0.59$30k125,000Nov 8, 2023

Questions about Matthew E Gormly

Answered from the filings on this page, as of the latest one.

Is Matthew E Gormly buying or selling?

Matthew E Gormly has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Matthew E Gormly's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew E Gormly has 0.

Where does Matthew E Gormly file Form 4?

Matthew E Gormly has filed Form 4 at JOB (GEE Group Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.